I’d buy these 3 buy-and-forget FTSE 100 stocks yielding 7%+

Harvey Jones is amazed at the income you can generate from top FTSE 100 (INDEXFTSE: UKX) stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Are you staggered by some of the yields available from top FTSE 100 stocks? I certainly am. The fact that I can pick out three companies yielding more than 7% in the blink of an eye is quite something. That kind of income will quickly roll up.

Compound glory

Let’s say I invest £10,000 in one of them. After five years, I will have £14,026, even if the share price does not grow at all in that time.

After 10 years, my money will have grown to £19,672, excluding all share price growth. If the stock still yields 7% by then, I will be getting a yield of 13.77% based on my original £10,000. These are crude calculations, but they show how yields matter for long-term investors. Just remember, dividends are not set in stone.

Aviva

The first 7% yielder I like is £16.7bn insurance giant Aviva (LSE: AV). I think this is a terrific income stock with a blistering forecast yield of 7.6%, covered 1.9 times by earnings. However, it has been a rotten growth stock, with the share price trading 15% lower than five years ago.

I have repeatedly been underwhelmed by Aviva’s share price, especially since it seems nicely priced to outperform, trading at just 6.9 times forecast earnings. As Kevin Godbold points out, Aviva is a cyclical stock with bumpy cash flow, and debt of £9.42bn in 2018. However, a sky-high yield and dirt-cheap valuation is always a difficult combination to resist. I’m hoping the current leadership shake-up may inject fresh energy. 

Tui Travel

Travel giant TUI Travel (LSE: TUI) has seen its share price halving over 12 months, while the yield has shot up as a result. Bargain hunters will be tempted, with the stock now valued at just 7.5 times earnings, which offers plenty of scope for a recovery.

Brexit uncertainty, sterling weakness and Spanish overcapacity hit the group, while last month it alerted markets that it could take a €200m hit from the grounding of its Boeing’s 737 MAX aeroplanes over safety concerns.

That could cast a shadow over its share price for some time while Rupert Hargreaves has warned of a possible share price cut if the problems continue. Right now, it looks riskiest of the three, but travel and tourism will only grow and I’d suggest brave investors buy at today’s low entry price then forget about short-term turbulence, as the TUI share price is ultimately heading for sunnier climes.

British American Tobacco

Tobacco stocks have long been one of the best sources of reliable dividends, and British American Tobacco (LSE: BATS) certainly fits that mould. The £70bn behemoth is up 25% over the past three months, although it still trades 40% lower than two years ago, as it has come under intense scrutiny from US regulators, which have been targeting big tobacco’s vaping and e-cigarettes operations.

The long-term decline of smoking in the West looks set to continue, with US cigarette volumes down 8.8% over the last year, Nielsen data shows. I believe the health message will ultimately spread to wealthy emerging market smokers too, but for now British American Tobacco continues to generate huge revenues, with more than $25bn expected this year.

Earnings are forecast to grow 5% this year and 7% next, and a yield of almost 7% with cover of 1.5 is still hard to resist.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »